ClinicalTrials.Veeva

Menu

Acceptability, Usability and Preliminary Effectiveness of ChatGPT in Increasing Seasonal Influenza Vaccination Uptake Among Older Adults in Hong Kong

The Chinese University of Hong Kong logo

The Chinese University of Hong Kong

Status

Not yet enrolling

Conditions

Behavior Change Interventions

Treatments

Behavioral: Access to a trained ChatGPT

Study type

Interventional

Funder types

Other

Identifiers

NCT06679647
SIV_ChatGPT

Details and patient eligibility

About

In this project, we will train a ChatGPT to provide real-time answers to questions related to the SIV for older adults in Hong Kong.

This study aims to evaluate the usability, acceptability, and preliminary effectiveness of the ChatGPT among 50 community-living people aged 65 years and above in Hong Kong.

The primary objectives are to evaluate the usability and acceptability (including the extent of usage and subjective experiences of behavioural, cognitive, and affective engagement) of the ChatGPT at the end of the 4-week intervention period (T1).

The secondary objectives are to evaluate the following conditions measured at T1, as compared to those measured at baseline (T0):

  1. Self-reported uptake of SIV in the past month.
  2. Changes in behavioural intention to receive SIV for the approaching flu season.
  3. Changes in knowledge and attitudes related to SIV.

Enrollment

50 estimated patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged ≥65 years;
  • Possession of a Hong Kong ID;
  • Able to speak and comprehend Cantonese;
  • Have a smartphone with internet access;
  • Have not taken SIV for the approaching flu season.

Exclusion criteria

  • With diagnosis of cognitive impairment or dementia;
  • Either blindness or deafness;
  • With known contraindications to the SIV as indicated by the Hong Kong Centre for Health Protection

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

ChatGPT group
Experimental group
Description:
Participants will be invited to use a trained ChatGPT which answers questions related to seasonal influenza vaccination. The functions can be used repeatedly throughout the intervention period (4 weeks), and participants will be free to spend as much time as they want on such functions.
Treatment:
Behavioral: Access to a trained ChatGPT

Trial contacts and locations

0

Loading...

Central trial contact

Zixin Wang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems